Our published study presented that CYP26 is a candidate gene family for assessing the risks of occurrence of oral/pharyngeal cancers and OPMD [10, 21, 22], and specific SNP combinations of CYP26 may be associated with increased risk of developing oral/pharyngeal cancers and OPMD. Here, CYP26A1 is linked to oculopharyngeal muscular dystrophy.